Which has grown faster, DVA or MRNA?

Over the past five years, DVA grew revenue faster — DVA at a 3.71% CAGR versus MRNA at -2.60%.

Is DVA or MRNA more profitable?

DVA runs the higher net margin — DVA at 5.65% versus MRNA at -143.55%.

Which has been the better investment, DVA or MRNA?

Over the past 5-year, DVA delivered the higher annualized total return — DVA at 10.61% versus MRNA at -25.58%. Past performance doesn't predict future results.

DaVita Inc. (DVA) vs Moderna, Inc. (MRNA)

DVA leads on 7 of 9 compared metrics.

A side-by-side comparison of DaVita Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — DVA vs MRNA

growth of $100 · last 8y

DVA +253.9%MRNA +168.3%DVA compounded faster

DVA MRNA

DVA vs MRNA: by the numbers

•MRNA is the larger company ($19.80B vs $13.40B market cap).
•DVA is profitable (5.65% net margin) while MRNA runs a net loss (-143.55%).
•DVA grew revenue faster over the past five years (3.71% vs -2.60% CAGR).

Which is better, DVA or MRNA?

Metric tally: DVA 7 · MRNA 2

It depends on what you're optimizing for:

GrowthDVA(faster 5Y revenue CAGR)

QualityDVA(higher ROIC)

Metrics side by side

Valuation

Metric	DVA	MRNA
P/E ratio	20.99	—
Forward P/E	14.05	—
P/S ratio	1.04●	8.86
P/B ratio	—	2.66
PEG ratio	2.54	—
EV / EBITDA	9.95	—
FCF yield	10.38%	—

Profitability

Metric	DVA	MRNA
Gross margin	31.10%●	-13.89%
Operating margin	15.01%●	-153.35%
Net margin	5.65%●	-143.55%
ROE	-114.70%	-43.12%●
ROIC	10.58%●	-29.70%

Growth (annualized)

Metric	DVA	MRNA
Revenue CAGR (5Y)	3.71%●	-2.60%
EPS CAGR (5Y)	8.25%	—
FCF CAGR (5Y)	6.13%	126.92%●
Total return CAGR (5Y)	11.28%●	-25.58%

Frequently asked

Which is better, DVA or MRNA?: It depends on your goal. growth: DVA (faster 5Y revenue CAGR); quality: DVA (higher ROIC). Across all compared metrics, DVA leads 7 to 2.
Which has grown faster, DVA or MRNA?: Over the past five years, DVA grew revenue faster — DVA at a 3.71% CAGR versus MRNA at -2.60%.
Is DVA or MRNA more profitable?: DVA runs the higher net margin — DVA at 5.65% versus MRNA at -143.55%.
Which has been the better investment, DVA or MRNA?: Over the past 5-year, DVA delivered the higher annualized total return — DVA at 10.61% versus MRNA at -25.58%. Past performance doesn't predict future results.

Go deeper

Full DVA analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio Moderna P/E ratio DaVita dividend yield Moderna dividend yield DaVita ROE Moderna ROE DaVita operating margin Moderna operating margin DaVita revenue growth Moderna revenue growth DaVita free cash flow Moderna free cash flow

DaVita & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.